Based on the theoretical notions above, some angiogenesis inhibitors, such as endostatin and AGO1, have been found to resist obesity [60–66], whereas proangiogenic factors such as ANT-2 exert anti-obesity effect [67]. The gene discussed is COL18A1; the disease is obesity disorder.